Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(59)
Filter by content year
(-)
2021
(59)
Filter by form group
Filter by category
(-)
Clinical
(59)
All
(55)
Collaborators
(48)
Other
(29)
Science
(14)
Events
(2)
Financial
(2)
Filter by category
Search
News
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
News
Pfizer und BioNTech stellen Antrag auf Erweiterung der Notfallzulassung ihres COVID-19-Impfstoffs für die Anwendung bei Jugendlichen
News
Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
News
Pfizer und BioNTech beantragen Erweiterung der bedingten Marktzulassung von COMIRNATY® für Jugendliche in der EU
News
Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
News
Pfizer and BioNTech Receive Health Canada Authorization of COVID-19 Vaccine in Adolescents
News
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für COVID-19-Auffrischungsimpfung in der Europäischen Union
News
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
News
Pfizer und BioNTech reichen bei der EMA Daten für die Impfung von Kindern im Alter von 5 bis <12 Jahren mit COMIRNATY® ein
News
Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age with COMIRNATY®
Pagination
Previous page
‹‹
Page 2
Next page
››